End-of-day quote
Korea S.E.
23:00:00 13/05/2024 BST
|
5-day change
|
1st Jan Change
|
12,360
KRW
|
+1.23%
|
|
-4.19%
|
+18.05%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
118,113
|
211,014
|
297,604
|
337,983
|
226,771
|
170,812
|
Enterprise Value (EV)
1 |
129,466
|
212,879
|
300,910
|
334,090
|
218,724
|
194,876
|
P/E ratio
|
16.3
x
|
16.4
x
|
21.9
x
|
34.9
x
|
-4,136
x
|
-59
x
|
Yield
|
-
|
-
|
-
|
0.33%
|
-
|
-
|
Capitalization / Revenue
|
1.62
x
|
2.21
x
|
2.62
x
|
2.69
x
|
1.74
x
|
1.34
x
|
EV / Revenue
|
1.78
x
|
2.23
x
|
2.65
x
|
2.66
x
|
1.68
x
|
1.53
x
|
EV / EBITDA
|
7.14
x
|
8
x
|
10.2
x
|
14.4
x
|
19.4
x
|
35.5
x
|
EV / FCF
|
-135
x
|
230
x
|
-43.5
x
|
-54.6
x
|
239
x
|
-8.24
x
|
FCF Yield
|
-0.74%
|
0.43%
|
-2.3%
|
-1.83%
|
0.42%
|
-12.1%
|
Price to Book
|
1.82
x
|
2.74
x
|
3
x
|
2.99
x
|
1.81
x
|
1.39
x
|
Nbr of stocks (in thousands)
|
14,810
|
14,578
|
14,955
|
14,955
|
16,314
|
16,314
|
Reference price
2 |
7,975
|
14,475
|
19,900
|
22,600
|
13,900
|
10,470
|
Announcement Date
|
21/03/19
|
30/03/20
|
23/03/21
|
22/03/22
|
23/03/23
|
21/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
72,736
|
95,486
|
113,547
|
125,567
|
130,567
|
127,410
|
EBITDA
1 |
18,125
|
26,616
|
29,445
|
23,204
|
11,263
|
5,489
|
EBIT
1 |
14,378
|
21,727
|
23,443
|
16,351
|
3,354
|
-3,142
|
Operating Margin
|
19.77%
|
22.75%
|
20.65%
|
13.02%
|
2.57%
|
-2.47%
|
Earnings before Tax (EBT)
1 |
11,862
|
21,576
|
21,819
|
16,389
|
3,421
|
-368.2
|
Net income
1 |
7,328
|
13,127
|
14,077
|
9,697
|
-52.19
|
-2,893
|
Net margin
|
10.07%
|
13.75%
|
12.4%
|
7.72%
|
-0.04%
|
-2.27%
|
EPS
2 |
489.5
|
883.7
|
909.5
|
648.4
|
-3.360
|
-177.3
|
Free Cash Flow
1 |
-956.4
|
923.8
|
-6,915
|
-6,115
|
915.1
|
-23,645
|
FCF margin
|
-1.31%
|
0.97%
|
-6.09%
|
-4.87%
|
0.7%
|
-18.56%
|
FCF Conversion (EBITDA)
|
-
|
3.47%
|
-
|
-
|
8.13%
|
-
|
FCF Conversion (Net income)
|
-
|
7.04%
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
75.00
|
-
|
-
|
Announcement Date
|
21/03/19
|
30/03/20
|
23/03/21
|
22/03/22
|
23/03/23
|
21/03/24
|
Fiscal Period: December |
2022 Q1
|
2022 Q3
|
---|
Net sales
1 |
30.71
|
31.53
|
EBITDA
|
-
|
-
|
EBIT
1 |
-
|
1.087
|
Operating Margin
|
-
|
3.45%
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
|
-
|
-
|
Net margin
|
-
|
-
|
EPS
|
-45.00
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
18/05/22
|
14/11/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
11,353
|
1,865
|
3,306
|
-
|
-
|
24,063
|
Net Cash position
1 |
-
|
-
|
-
|
3,892
|
8,047
|
-
|
Leverage (Debt/EBITDA)
|
0.6264
x
|
0.0701
x
|
0.1123
x
|
-
|
-
|
4.384
x
|
Free Cash Flow
1 |
-956
|
924
|
-6,915
|
-6,115
|
915
|
-23,645
|
ROE (net income / shareholders' equity)
|
13.9%
|
21.1%
|
19%
|
10.9%
|
1.79%
|
-0.05%
|
ROA (Net income/ Total Assets)
|
7.46%
|
9.33%
|
8.09%
|
4.6%
|
0.85%
|
-0.79%
|
Assets
1 |
98,286
|
140,658
|
174,087
|
210,998
|
-6,151
|
366,727
|
Book Value Per Share
2 |
4,377
|
5,279
|
6,639
|
7,569
|
7,667
|
7,530
|
Cash Flow per Share
2 |
1,894
|
2,850
|
3,721
|
4,693
|
3,257
|
2,426
|
Capex
1 |
12,028
|
8,821
|
21,329
|
22,861
|
23,782
|
27,751
|
Capex / Sales
|
16.54%
|
9.24%
|
18.78%
|
18.21%
|
18.21%
|
21.78%
|
Announcement Date
|
21/03/19
|
30/03/20
|
23/03/21
|
22/03/22
|
23/03/23
|
21/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +18.05% | 149M | | +16.92% | 66.52B | | +3.14% | 50.34B | | +18.14% | 42.01B | | +20.88% | 26.68B | | +12.41% | 19.97B | | +1.23% | 17.32B | | -23.54% | 15.7B | | +1.42% | 15.53B | | -11.92% | 14.99B |
Other Specialty Chemicals
|